Champions Oncology (CSBR) Gains from Investment Securities (2018 - 2025)
Historic Gains from Investment Securities for Champions Oncology (CSBR) over the last 8 years, with Q3 2025 value amounting to $38000.0.
- Champions Oncology's Gains from Investment Securities rose 270.27% to $38000.0 in Q3 2025 from the same period last year, while for Oct 2025 it was -$329000.0, marking a year-over-year increase of 4197.53%. This contributed to the annual value of -$293000.0 for FY2025, which is 3264.37% up from last year.
- Latest data reveals that Champions Oncology reported Gains from Investment Securities of $38000.0 as of Q3 2025, which was up 270.27% from -$405000.0 recorded in Q2 2025.
- Over the past 5 years, Champions Oncology's Gains from Investment Securities peaked at $2.2 million during Q2 2021, and registered a low of -$605000.0 during Q2 2024.
- Over the past 5 years, Champions Oncology's median Gains from Investment Securities value was $38000.0 (recorded in 2025), while the average stood at $174583.3.
- As far as peak fluctuations go, Champions Oncology's Gains from Investment Securities skyrocketed by 5632500.0% in 2021, and later tumbled by 26440.22% in 2024.
- Quarter analysis of 5 years shows Champions Oncology's Gains from Investment Securities stood at -$66000.0 in 2021, then skyrocketed by 404.55% to $201000.0 in 2022, then dropped by 15.92% to $169000.0 in 2023, then plummeted by 78.11% to $37000.0 in 2024, then grew by 2.7% to $38000.0 in 2025.
- Its Gains from Investment Securities was $38000.0 in Q3 2025, compared to -$405000.0 in Q2 2025 and $38000.0 in Q1 2025.